C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411)
12/2002
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100341A2 Compounds for the treatment of metabolic disorders
12/19/2002	WO2002070541A3 Peptide deformylase inhibitors
12/19/2002	WO2002042248A3 Naphthalene derivatives
12/17/2002	US6495719 Histone deacetylase inhibitors
12/17/2002	US6495597 N-formyl hydroxylamine derivatives
12/12/2002	WO2002098901A2 Peptide deformylase inhibitors
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263712A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/11/2002	EP0624155B2 Carbamates and plant-protecting agents containing them
12/11/2002	CN1384097A Prepn process of acetohydroxamic acid
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/10/2002	US6492424 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
12/09/2002	WO2001096366A2 Dipeptide inhibitors for the blood-clotting factor xa
12/09/2002	CA2412181A1 Dipeptide inhibitors for the blood-clotting factor xa
12/05/2002	US20020183558 Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds
12/05/2002	US20020183513 Tricyclic alkylhydroxamate derivatives
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
11/2002
11/27/2002	EP1260504A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives
11/27/2002	EP1017670B1 Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
11/27/2002	CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/26/2002	CA2113650C N-ethyl hydroxamic acid chelants
11/21/2002	WO2002092553A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/21/2002	CA2446740A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
11/19/2002	US6482849 Inhibitors of α4β1 mediated cell adhesion
11/19/2002	US6482827 Matrix metalloproteinase inhibitors
11/13/2002	EP1256576A1 Fused imidazolium derivatives
11/13/2002	EP1255727A1 Acetal hydroxylamine compounds
11/13/2002	EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002	EP0920413B1 Boronic compound complexing reagents and complexes
11/12/2002	US6479663 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/07/2002	WO2002088071A1 20-hydroxyeicosatetraenoic acid production inhibitors
11/07/2002	US20020165167 Bacterial polypeptide deformylase (PDF) inhibitors, N-formyl hydroxylamine derivatives
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	EP1012137B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
11/06/2002	CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/05/2002	US6476264 N-(4-carbamimidoyl-phenyl)-glycine derivatives
10/2002
10/31/2002	WO2002085883A1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors
10/31/2002	WO2001070675A3 Inhibitors of histone deacetylase
10/31/2002	US20020161041 Resorcinol derivatives
10/31/2002	CA2442994A1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors
10/30/2002	EP1005449B1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same
10/29/2002	US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/23/2002	EP1250317A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
10/23/2002	EP1250316A1 Method for producing n-alkoxy-n-alkylamides
10/23/2002	EP1032631B1 O-substituted n,n-diacylhydroxylamine bleach activators and compositions employing the same
10/17/2002	WO2002081426A1 Peptide deformylase inhibitors
10/17/2002	WO2002050081A3 Antimicrobial agents
10/17/2002	WO2001070664A3 Lipoxin analogs and methods for the treatment of periodontal disease
10/17/2002	US20020151535 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent
10/17/2002	US20020148759 Reaction of the methyl or ethyl ester of a fatty acid having 6 to 22 carbon atoms with a hydroxylamine salt and an alkali metal hydroxide in the presence of water, either a hydrocarbon oil or a fatty oil
10/15/2002	US6465686 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/10/2002	WO2002079144A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002	WO2002079136A1 Enantiomerically selective cyclopropanation
10/10/2002	DE10115994A1 (p-Amino-hydroxyphenyl)acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel (P-amino-hydroxyphenyl) acrylamide derivatives and compositions containing these compounds colorant
10/10/2002	CA2443304A1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/10/2002	CA2442934A1 Enantiomerically selective cyclopropanation
10/09/2002	EP1246795A2 Antibacterial agents
10/08/2002	US6462179 Conjugation to peptides, proteins, hormones, polysaccharides, nucleic acids, haptens, drugs, ligands, toxins, halophors, and other macromolecules
10/08/2002	US6462042 Tumor necrosis factor alpha converting enzyme inhibitors; inflammatory diseases, autoimmune diseases, cancer, cardio-vascular diseases, rheumatoid arthritis, osteoarthritis, osteoporosis, neurodegeneration, alzheimer's disease, stroke
10/08/2002	US6462023 Cytostatic agents
10/03/2002	WO2002076941A2 Histone deacetylase inhibitors
10/03/2002	WO2002076395A2 Agents and methods for treatment of cancer
10/03/2002	US20020143196 Histone deacetylase inhibitors
10/03/2002	US20020143052 Histone deacetylase inhibitors
10/03/2002	US20020143037 For therapy of cancer, hematological disorders, e.g., hemoglobinopathies, and genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy.
10/03/2002	CA2783647A1 Histone deacetylase inhibitors
10/03/2002	CA2441394A1 Agents and methods for treatment of cancer
10/02/2002	EP0915832B1 Boronic compound complexing reagents and highly stable complexes
10/01/2002	US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
09/2002
09/26/2002	WO2002074731A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/26/2002	WO2002074298A1 Il-6 production inhibitors
09/26/2002	WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient
09/26/2002	US20020137978 Using as catalyst ruthenium or osmium carbene complexes containing an imidazolidine ligand
09/26/2002	US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example
09/26/2002	CA2445754A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
09/25/2002	EP1242367A1 2-[3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors
09/24/2002	US6455531 Metalloproteinase inhibitors
09/24/2002	CA2096223C Treatment for tissue ulceration
09/19/2002	US20020133025 Agriculture
09/19/2002	US20020132849 2-Amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
09/19/2002	DE10113027A1 3-Diaminophenyl-acrylamide derivatives or their physiologically acceptable, water-soluble salts, used as developers in combination with couplers in oxidative dye formulations, especially for dyeing hair are new
09/18/2002	EP1240152A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
09/17/2002	US6452044 Benzenedicarboxylic acid derivatives
09/17/2002	US6452010 Process for the preparation of hydroxamic acid derivatives
09/17/2002	US6451859 C16 unsaturated FP-selective prostaglandins analogs
09/12/2002	WO2002070541A2 Peptide deformylase inhibitors
09/12/2002	US20020128510 Antiarthritic agents; rheumatic diseases; osteoarthritis; inhibition of the inducible nitric oxide synthase - induced after activation of vascular smooth muscle, macrophages, endothelial cells by enotoxin and cytokines
09/12/2002	US20020127202 Compounds and compositions for delivering active agents
09/12/2002	CA2439827A1 Peptide deformylase inhibitors
09/11/2002	EP1237868A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors
09/11/2002	EP1237867A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors
09/11/2002	CN1090614C N-(aroyl) glycine hydroxamic acid derivatives and related compounds
09/10/2002	US6448278 Antiscarring agent
09/06/2002	WO2002068379A2 Novel bifunctional chelating compounds containing hydroxamic acid residues
09/06/2002	WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors
09/06/2002	CA2753395A1 Novel bifunctional chelating compounds containing hydroxamic acid residues
09/04/2002	EP1235791A1 A multistage process for the preparation of highly pure deferoxamine mesylate salt
09/03/2002	CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors
08/2002
08/29/2002	US20020120149 Substituted hydrazine derivatives

1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 45